Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-control...

by Anca D Askanase, Enxu Zhao, Julie Zhu, Erin Connolly-Strong
Published 2020-12-01

Correction: targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice

by Anca D Askanase, Enxu Zhao, Julie Zhu, Erin Connolly-Strong
Published 2020-12-01

A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse

by Jeffrey Kaplan, Tamara Miller, Matthew Baker, Bryan Due, Enxu Zhao
Published 2020-12-01

Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

by Anca D. Askanase, Enxu Zhao, Julie Zhu, Roman Bilyk, Richard A. Furie
Published 2020-09-01